Eventide Asset Management, LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:01 pm Purchase |
2024-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Eventide Asset Management, LLC | 2,220,000 3.460% |
2,220,000 (New Position) |
Filing |
| 2024-11-14 12:19 pm Purchase |
2024-09-30 | 13G | Inozyme Pharma, Inc. INZY |
Eventide Asset Management, LLC | 4,134,436 6.440% |
954,599 (+30.02%) |
Filing |
| 2024-02-14 11:54 am Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Eventide Asset Management, LLC | 3,179,837 5.150% |
3,179,837 (New Position) |
Filing |